Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
19/06/26	0.1878 €	-0.63%	48,597
18/06/26	0.1890 €	+1.29%	170,013
17/06/26	0.1866 €	-1.79%	58,788
16/06/26	0.1900 €	-1.04%	121,161
15/06/26	0.1920 €	+4.01%	403,845

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 16:55:00 19/06/2026 BST			5-day change	1st Jan Change
0.1878 ^EUR	-0.63%		+1.73%	-14.25%

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	57.65M 66.12M 53.4M 49.98M 93.74M 6.24B 94.31M 633M 245M 3.07B 248M 243M 10.66B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	57.78M 66.27M 53.51M 50.09M 93.95M 6.25B 94.52M 635M 246M 3.08B 249M 243M 10.69B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale
06-11	Une bonne grosse purge avant SpaceX
06-11	Klea Holding : Klea Pharmaceuticals annonce le démarrage de son activité avec un puissant partenaire

1 day	-0.63%
1 week	+1.73%
Current month	-4.57%
1 month	-0.95%
3 months	+10.47%
6 months	-20.93%
Current year	-14.25%

1 week	0.18	0.19
1 month	0.18	0.2
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.56
5 years	0.08	0.59
10 years	0.08	172.4

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Date	Insider	Type	Quantity	% Market Cap.
03-10	Raphael Smila	Buy	95,000	0.0309%
03-10	Raphael Smila	Buy	40,000	0.0130%
03-10	Raphael Smila	Buy	10,000	0.0033%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.63%	+1.73%	+4.22%	-63.64%	66.12M
CVS HEALTH CORPORATION	-0.85%	-3.57%	+47.10%	+45.19%	125B
HCA HEALTHCARE, INC.	-3.35%	-3.10%	-0.45%	+29.33%	83.23B
FRESENIUS SE & CO. KGAA	+0.76%	+5.15%	-4.85%	+55.39%	25.59B
QUEST DIAGNOSTICS INCORPORATED	-1.40%	-3.97%	+8.47%	+40.69%	21.59B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.05%	+2.59%	-11.63%	-21.60%	20.34B
TENET HEALTHCARE CORPORATION	-3.32%	-1.20%	+2.98%	+120.03%	14.86B
REDE D'OR SÃO LUIZ S.A.	+1.05%	-1.41%	-4.73%	+0.45%	14.38B
DAVITA INC.	-1.27%	-0.36%	+53.11%	+112.98%	13.35B
FRESENIUS MEDICAL CARE AG	-1.36%	+2.60%	-11.71%	-5.22%	12.54B
Average	-1.03%	+0.50%	+8.25%	+31.36%	33.14B
Weighted average by Cap.	-1.40%	-0.66%	+18.81%	+39.82%

	2024	2025
Net sales	17.26M 19.8M 15.99M 14.96M 28.06M 1.87B 28.23M 190M 73.5M 919M 74.31M 72.71M 3.19B	22.17M 25.42M 20.53M 19.22M 36.04M 2.4B 36.26M 244M 94.39M 1.18B 95.43M 93.38M 4.1B
Net income	1.4M 1.61M 1.3M 1.22M 2.28M 152M 2.3M 15.44M 5.98M 74.84M 6.05M 5.92M 260M	2.28M 2.62M 2.11M 1.98M 3.71M 247M 3.73M 25.06M 9.71M 122M 9.82M 9.61M 422M
Net Debt	2.58M 2.95M 2.38M 2.23M 4.19M 279M 4.21M 28.29M 10.96M 137M 11.09M 10.85M 476M	125K 143K 116K 108K 203K 13.53M 204K 1.37M 532K 6.66M 538K 527K 23.12M